Tags

Type your tag names separated by a space and hit enter

COVID-19 lockdown increased diabetic mortality, morbidity and costs in Italy.
PharmacoEcon Outcomes News. 2021; 882(1):7.PO

Pub Type(s)

News

Language

eng

PubMed ID

34276206

Citation

"COVID-19 Lockdown Increased Diabetic Mortality, Morbidity and Costs in Italy." PharmacoEconomics & Outcomes News, vol. 882, no. 1, 2021, p. 7.
COVID-19 lockdown increased diabetic mortality, morbidity and costs in Italy. PharmacoEcon Outcomes News. 2021;882(1):7.
(2021). COVID-19 lockdown increased diabetic mortality, morbidity and costs in Italy. PharmacoEconomics & Outcomes News, 882(1), 7. https://doi.org/10.1007/s40274-021-7841-6
COVID-19 Lockdown Increased Diabetic Mortality, Morbidity and Costs in Italy. PharmacoEcon Outcomes News. 2021;882(1):7. PubMed PMID: 34276206.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - COVID-19 lockdown increased diabetic mortality, morbidity and costs in Italy. Y1 - 2021/07/10/ PY - 2021/7/19/entrez PY - 2021/7/20/pubmed PY - 2021/7/20/medline SP - 7 EP - 7 JF - PharmacoEconomics & outcomes news JO - PharmacoEcon Outcomes News VL - 882 IS - 1 SN - 1179-2043 UR - https://www.unboundmedicine.com/medline/citation/34276206/COVID-19_lockdown_increased_diabetic_mortality,_morbidity_and_costs_in_Italy. L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34276206/ DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.